CTT PHARMACEUTICAL HOLDINGS, INC.
Income Statement
| Line Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | — | — | — | — | — | — |
| SG&A Expense | — | $17.6K | $3.8K | $158.4K | $316.4K | $309.5K |
| Operating Income | — | $-672.2K | $-18.9K | $-1.2M | $-757.9K | $-2.1M |
| Operating Margin | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — |
| Net Income | — | $-672.2K | $-18.9K | $-1.0M | $3.7M | $-1.1M |
| Net Margin | — | — | — | — | — | — |
| EPS (Basic) | — | $-0.04 | $0.01 | $-0.11 | $0.42 | $-0.13 |
| EPS (Diluted) | — | $-0.04 | $0.01 | $-0.11 | $0.40 | $-0.13 |
| Shares Outstanding (Basic) | 21.3M | 19.5M | 9.4M | 9.4M | 8.9M | 8.5M |
| Shares Outstanding (Diluted) | 21.3M | 19.5M | 9.4M | 9.4M | 9.5M | 8.5M |
| Dividends Per Share | — | — | — | — | — | — |